SeaStar Medical
Company Details
Status: Private
Employees: 11-50
Location:
3513 Brighton Blvd, Ste 410, Denver, CO 80216, US
Type:
sample
Technology:
sample
About: SeaStar Medical is a commercial-stage medical technology company based in Denver, Colorado, focused on developing extracorporeal therapies to combat excessive inflammation in critically ill patients. Incorporated in 2020, the company aims to improve patient outcomes by transforming immune responses or removing harmful cytokines that contribute to organ failure.
The flagship product, the Selective Cytopheretic Device (SCD), is designed to neutralize overactive immune cells and halt cytokine storms, which can lead to severe hyperinflammation. SeaStar Medical also offers QUELIMMUNE (SCD-PED), the first FDA-approved treatment for life-threatening acute kidney injury in critically ill pediatric patients. The company has received Breakthrough Device Designation for multiple therapeutic indications, facilitating a faster approval process.
Led by a team of experienced professionals, including critical care physicians, SeaStar Medical targets critical care clinicians and hospitals, providing innovative solutions for managing severe inflammatory conditions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
SeaStar Medical | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.